Orlistat
Back to searchMolecule Structure
Scientific Name
Orlistat
Description of the Drug
Orlistat is a reversible inhibitor of gastrointestinal lipases indicated for weight loss and weight maintenance.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01083
http://www.drugbank.ca/drugs/DB01083
Brand Name(s)
Alli, Beacita, Xenical
Company Owner(s)
Glaxosmithkline Consumer Healthcare, Cheplapharm Arzneimittel Gmbh
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Pancreatic lipase | SINGLE PROTEIN | INHIBITOR | CHEMBL1812 |
| Gastric lipase | SINGLE PROTEIN | INHIBITOR | CHEMBL1796 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL16408 | ||
| PharmGKB | PA164776864 | ||
| Human Metabolome Database | HMDB0015215 | ||
| DrugBank | DB01083 | ||
| PubChem: Thomson Pharma | 14810727 | 14933128 | |
| PubChem | 3034010 | ||
| LINCS | LSM-5724 | ||
| Nikkaji | J391.912I | ||
| BindingDB | 24567 | ||
| EPA CompTox Dashboard | DTXSID8023395 | ||
| DrugCentral | 1996 | ||
| Metabolights | MTBLC94686 | ||
| Brenda | 17882 | ||
| ChemicalBook | CB2431985 | ||
| Guide to Pharmacology | 5277 | ||
| rxnorm | XENICAL | ORLISTAT | ALLI |
| PubChem: Drugs of the Future | 12013644 | ||
| ChEBI | 94686 | ||
| ZINC | ZINC000008214635 |
